Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 33.30
-0.25 (-0.75%)
Nov 3, 2025, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 16.82 billion as of October 31, 2025. Its market cap has increased by 7.61% in one year.
Market Cap
16.82B
Enterprise Value
17.57B
Revenue
6.00B
Ranking
n/a
PE Ratio
22.08
Stock Price
33.30
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 16.82B, an increase of 2,783.47%. That is a compound annual growth rate of 18.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 16.82B | 16.04% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | 6.81B | 20.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |